quoted lung function test in clinical practice However, many authors have now shown that the decline accelerates with ageing. 5 7 10-12 As a result of these models of change in FEV 1 , at any given time in adulthood FEV 1 is determined by three factors: (1) the maximally attained level of lung function during early adulthood; (2) the onset of decline of lung function or, alternatively, the duration of the plateau phase; and (3) the rate of decline of lung function ( fig  1) . 13 In other words, from one low measurement of FEV 1 in an adult it is impossible to determine whether the reduced lung function is due to not having achieved a high maximum during early adulthood, to having had a shortened plateau phase, to having an accelerated rate of decline, or to any combination of these. coefficient in the reference equations that are dingen-Vlagtwedde study cross sectional age coefficients derived from the first survey overemployed in their lung function laboratory. For instance, when using the ECCS equation, 9 the estimated the decline observed over 12 years of follow up in 20 year old individuals by 35 ml/ average yearly decline from 25 years of age is assumed to be 29 ml/year for men and 25 ml/ year. 6 By contrast, at the age of 60 the same procedure underestimated the decline by 11 ml/ year for women. This essentially assumes that a 40 year old person will decline with the same year (fig 2A) . Similarly, in the Six Cities study the actual decline was underestimated by cross ml/year as a 40 year old did 10 or 20 years ago when the equations were assembled. Moreover, sectional estimates by 19 ml/year at the age of 75 ( fig 2B) . 11 The latter finding would be it assumes that the equations were constructed in a longitudinal fashion -that is, actually compatible with a survivor effect in cross sectional studies -that is, a selection of those looking at decline over time -whereas most equations used are derived from cross sectional having better lung function who still contribute to the data at an older age. This would cause analyses.
2-4 9 11 Several studies have now shown that remarkable discrepancies exist between cross sectional analyses to overestimate lung function at an older age and hence underestimates of annual decline derived from cross sectional data sets as opposed to longitudinal estimate the decline. Such a survivor effect was indeed demonstrable, but Ware and colleagues data sets. 6 7 11 14 15 In the two larger data sets 6 11 the decline in FEV 1 assessed longitudinally show that in their study it explained only a small part of the discrepancies at older age.
11
within individuals up to about 50 years of age has been found to be smaller than predicted Apart from the mathematical and methodological problems in the actual production of from cross sectional analyses, whilst after that age the reverse is the case. In the Dutch Vlaar-reference equations as mentioned above, adgroup.bmj.com on June 22, 2017 -Published by http://thorax.bmj.com/ Downloaded from ditional problems with defining decline may authors. 9 20-25 For meaningful use of reference values to interpret a manoeuvre of FEV 1 in also arise from so called cohort and period effects.
15 Cohort effects are caused by factors a lung function laboratory, three important conditions have to be met: (1) the measurement such as environmental and nutritional changes and would, for example, explain why lung func-of FEV 1 derived in the laboratory should be reliable and its sources of variation should be tion in young adults is higher now than it was 40 years ago. As an example, in the Six Cities known and appreciated; 20 (2) the measurement techniques and conditions in the local laboratstudy Ware et al showed that part of the discrepancy between longitudinal and cross sec-ory should be comparable with those used in the study giving rise to the reference values; tional data on the decline in lung function is due to age related changes in height in younger and (3) the population from which the reference values are derived should have charcohorts.
11 Additionally, in many population studies of healthy non-smoking subjects no acteristics encompassing those of the subject under study. Only when all three conditions allowance is made for environmental tobacco smoke, and this might also lead to cohort effects have been met can a meaningful value for FEV 1 % predicted be found and interpreted. A list since smoking rates (and therefore passive smoking rates) are falling sharply in many of factors involved is given in table 1.
Both the European Respiratory Society and countries.
16 17 Changes in genetic make up may also give rise to cohort effects, but usually occur the American Thoracic Society have produced detailed recommendations on the procedures over much longer time spans. Glindmeyer et al have attempted to quantify the cohort effect and techniques of lung function measurements which have recently been updated. 9 26 27 In adfor vital capacity over a period of 135 years. They estimated the cumulative cohort effect in dition, the European guidelines provide ref-
erence equations which are a composite of 25 year old men of 173 cm height to be close to 5 ml/year, 14 signifying that each former gen-earlier studies. 9 By contrast, the American Thoracic Society has left the choice of reference eration of 25 years earlier had a vital capacity 125 ml lower than in the subsequent gen-values to the clinician, stating that although biological plausibility and simplicity in the eration! From the Vlaardingen-Vlagtwedde study it has been estimated that the effect might model used to develop prediction equations are important issues, neither is as important as even be twice as high.
15
In addition to cohort effects, period effects appropriate group selection and comparable instrumentation and technique. 25 It is imcan exist. Period effects include factors such as changes in techniques and apparatus during portant to realise that some reference values currently in use have been put together before the time a study is performed, and learning effects in the sense of achieving higher spiro-these recommendations were published and hence need not be the same as those currently metric values with experience. 11 14 18 Xu and colleagues have calculated period and cohort in use in any given laboratory. This is especially true for the reference values for FEV 1 of the effects separately in the 24 year follow up study of Vlaardingen-Vlagtwedde and found both to European Community for Coal and Steel which are derived from 20 unrelated studies perbe present. 15 Looking at period effects in four different survey periods, they found an increase formed between 1960 and 1980 with varying apparatus, measurement conditions, and techin the average level of FEV 1 of 250 ml for men and 219 ml for women in the last survey period niques. 9 Five commonly used and two new reference (1985) (1986) (1987) (1988) (1989) (1990) ) compared with the first survey period (1973) (1974) (1975) (1976) (1977) (1978) . 15 An overview of the in-equations are listed in table 2. Newer equations tend to be derived by increasingly elaborate tricacies of longitudinal data analysis as opposed to cross sectional analyses has recently statistical techniques such as polynomial equations 5 10 12 and splines. 8 28 As a result the been provided by Schouten and Tager. 19 clinician is left with either more complex equations for which software is sometimes available 5 10 12 or even with no equations at all as, Reference values for healthy neversmokers for instance, in the case of spline and smoothing techniques. 28 In the latter case predicted value Problems associated with the use of reference values have been dealt with by several data can be used only within the same study.
group.bmj.com on June 22, 2017 -Published by http://thorax.bmj.com/ Downloaded from The differences between prediction equa-attained, the time of onset of decline, and the tions might at first sight seem to be of little rate of decline. 32 The influence of enrelevance. However, to demonstrate that this vironmental tobacco smoke begins in utero 33 34 is by no means always the case we calculated and has been convincingly documented in from different reference equations for a meas-infancy. 35 36 Active smoking has its effect on ured FEV 1 the corresponding % predicted lung function within a few years of taking up FEV 1 . For a 60 year old short man the measured the habit in adolescents, affecting both level FEV 1 can correspond to 65-102% predicted and rate of growth. 32 37 As a consequence, due depending on the regression equation used to smoking during adolescence a lower max- (table 3) . Thus, the choice of reference equa-imum or peak level of FEV 1 is achieved (fig tions that are most suitable for the individual 1).
1 38 39 Tager and colleagues estimated the under study is of utmost importance. With life FEV 1 to be, on average, 390 ml lower for boys expectancy increasing, it is also important to who smoke and 360 ml for girls. 38 realise that the current equations are less suitSeveral authors have shown that smoking able for those aged above 75 years and new sets shortens the plateau phase of FEV 1 . 1 6 8 32 The for the elderly have recently been proposed. [29] [30] [31] third factor determining the FEV 1 at any given Reference equations for non-Caucasian sub-time point -the rate of decline after the plateau jects -for example, Afro-Americans -are phase -is the factor that has traditionally redifferent from those for Caucasian subjects. A ceived the most attention (table 4). Fletcher discussion of these non-Caucasian equations is and colleagues were probably the first to look beyond the scope of this paper.
12 25 26 longitudinally at the effect of smoking on the level and decline of lung function in their landmark study of London workers.
18 They docu-FEV 1 by smoking category mented that smokers had a steeper decline in The reference equations commonly used to FEV 1 than did non-smokers, and also that only calculate the predicted FEV 1 value relate only a small percentage of all smokers progress to to healthy individuals. Smokers are excluded develop clinically manifest obstructive lung disfrom this definition as smoking affects all three ease with much more loss of lung function, the factors that determine the level of FEV 1 at so-called susceptible smokers. 18 40 Subjects who any given time -namely, the maximal FEV 1 already have some airways obstruction were found to be the ones most at risk for subsequent accelerated decline, for which they coined the many more cross sectional studies in smokers to increase in weight associated with smoking cessation therefore counteracts to some degree than there are longitudinal studies. It should again be stated that the cross sectional studies the positive effect of smoking cessation itself on FEV 1 . by design will not be able to separate reliably the effects of smoking on the maximal level of FEV 1 achieved in early adulthood, on the duration of the plateau phase, or on the rate Other risk factors associated with accelerated decline of FEV 1 of decline. 19 Important observations have been reported in studies which document a dose-When interpreting the results of (changes in) FEV 1 , it is important to realise that smoking is response relation in the effect of smoking on the rate of decline in pulmonary function, the not the only known risk factor for accelerated decline in lung function, though it is by far the effect being higher with more cigarettes, more years, or more pack years smoked. 18 43-46 There most important one both in epidemiological settings and in patients with already manifest are, however, substantial areas of uncertainty as to why only a minority of smokers are sus-disease. Some patients with asthma show accelerated decline in FEV 1 . [61] [62] [63] [64] [65] Since chronic ceptible, and whether or not there are safe thresholds for smoking in those subjects. It obstructive pulmonary disease (COPD) is usually associated with smoking, and smoking is prudent to think there is not. The early identification of the susceptible smoker could is the primary risk factor for accelerated decline, it is unclear whether the disease by itself gives lead to more targeted smoking prevention or smoking cessation programmes. [47] [48] [49] Smoking rise to accelerated decline. In patients with COPD and mild to moderate obstruction, cescessation has been shown in many studies to result in normalisation of the decline in FEV 1 sation of smoking seems to move the decline in pulmonary function back into the normal to the rate of never smokers 42 44 46 50 51 and this has recently been confirmed in a large scale range. 52 Risk factors for accelerated decline among subjects with already clinically manifest intervention study. 52 There seems to be a small positive effect on the level of FEV 1 separate obstructive disease have also recently been reviewed; 49 next to smoking, increased airway from its effect on declining pulmonary function. 52 Pipe and cigar smoking has also been hyperresponsiveness was the only factor consistently found to predict a more rapid defound to accelerate the decline in FEV 1 . 44 53 There is, to date, little clarity on sex differences cline. [66] [67] [68] Studies of general population samples (as opposed to patients with already manifest in the susceptibility to cigarette smoke, with similar numbers of studies reporting that men disease) have identified the following risk factors for accelerated decline which are reviewed are more susceptible 42 51 53-55 and that women are more vulnerable.
16 37 44 56 57 It has been shown elsewhere: airways hyperresponsiveness, 69 70 atopy, 69 childhood respiratory infections, 71 air by several authors that symptomatic smokers have larger declines than non-symptomatic pollution, 72 and occupational hazards. smokers. 8 58 Although weight per se does not enter as a significant factor into any of the regression equations for FEV 1 given in the Is this lung function abnormal?
Measurement of lung function is subject to table, a negative effect of weight gain on decline in pulmonary function has recently been re-large variation and age, height, and sex in prediction equations only account for some ported in two studies. 59 60 The loss of FEV 1 due group.bmj.com on June 22, 2017 -Published by http://thorax.bmj.com/ Downloaded from 40-50% of any forced vital capacity meas-from a statistical perspective, 5 76 80 and although not in vogue in pulmonary medicine, it has ured. 20 Such data are not available for FEV 1 but should be comparable. It is less appreciated been used to great advantage for many years in paediatrics for growth curves (height for age, that the interpretation of the results of a given test result by pulmonary physicians is also weight for height, etc). In cases where the distribution of values around the predicted subject to considerable variation; when 26 pulmonary physicians were asked to grade ob-value is Gaussian across all ages and heights, the 95% percentile should be the same as 1.64 struction in 10 consecutive patients as none, mild, moderate, or severe, only 60% agreement times the standard deviation of the residuals (sometimes called the residual standard dewas obtained.
21
Part of this confusion stems from a lack of common concept of viation, RSD). This is the abovementioned second method. In the case of the European normality.
20 22-24 75-77 Three methods are available to determine the lower limit of normal Community for Coal and Steel equations, the distribution in fact turns out to be sufficiently FEV 1 : (1) a fixed percentage below the predicted value; (2) a fixed point of the normal Gaussian to justify the use of 1.64 RSD or the 5th centile as the cut off value, representing Gaussian distribution, most commonly the 5th percentile; and (3) the actual percentile curves. values of 0.84 l as the cut off for men and 0.62 l for women. 9 This method is easier to Unfortunately, the first method of assessing "abnormality" is still by far the most commonly implement in clinical practice than the use of percentile curves for different heights and sexes. used method by clinicians and 80% predicted is the commonly used limit. This method has The underlying assumption is that it is deemed acceptable that 5% of the normal population no logical background and has, in fact, been proven to be inappropriate by many authors be classified as having an abnormally low lung function. Results of function tests should then over the last four decades.
2 5 9 12 25 78-81 Why does the method persist? Probably for two reasons be expressed in the number of RSDs below predicted instead of in % predicted. Only a few -primarily because it is the easiest method to use, and also because it has been used for such lung function laboratories appear so far to have taken up this statistically more logical apa long period both by clinicians and researchers. The reason why the fixed percentage criterion proach, and many clinicians remain reluctant.
Likewise, selection of patients for having an should be abandoned is that the boundary between acceptable and unusually low function abnormal lung function in a research setting should preferably also be performed utilising in large population studies is not proportional to the mean value, but instead the distribution RSD. 82 Fortunately, software of newer lung function devices increasingly renders the FEV 1 is homoscedastic -the loss, for instance, of 0.84 litres is just as unusual for an old as for a deviation from normal not only in % predicted but also in RSD below predicted. For children, young man, and for a tall as for a short man. In other words, 5% of the healthy young tall in contrast to adults, the standard error of the estimate is indeed proportional to predicted population have values as low or lower than this volume below predicted, and similarly 5% mean and hence a fixed percentage of predicted can be used as the lower boundary in children.
26
of the short old population (fig 3) . 78 The second and third methods of assessing normality have With regard to the assessment of a given level of FEV 1 , the calculation of boundaries for a common statistical basis. The third method, which uses percentile curves, is the best method acceptable versus accelerated decline in lung which influences all three determinants of an 24 
